Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9311645 | Urology | 2005 | 5 Pages |
Abstract
Observed late RT toxicity rates were generally similar in patients who did and did not receive HT. Thus, increased late RT toxicity should not be a major concern when deciding to add HT to RT for treatment of localized prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ashesh B. Jani, John Gratzle,